Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bacillus Subtilis in Parkinson's Disease
Sponsor: University of Edinburgh
Summary
The aim of this study is to evaluate whether the administration of Bacillus Subtilis influences gut and blood biomarkers relevant to the proposed mechanism(s) of action, as well as being acceptable as a regular supplement for people with Parkinson's disease.
Official title: Effects of Bacillus Subtilis on Blood and Gut Biomarkers in Parkinson's Disease
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2023-05-02
Completion Date
2025-11-20
Last Updated
2026-04-08
Healthy Volunteers
No
Conditions
Interventions
Bacillus Subtilis
Bacillus Subtilis 1 capsule once daily in the morning (consisting of 10x10\^9 Colony Forming Units)
Placebo
1 visually identical placebo capsule once daily in the morning using the same carrier (microcrystalline cellulose) as the active (but not containing Bacillus Subtilis)
Locations (2)
Norwegian Centre for Movement Disorders, Stavanger University Hospital
Stavanger, Norway
NHS Lothian
Edinburgh, United Kingdom